On April 23, 2025, Aerovate Therapeutics announced a change in the cash dividend payment date associated with a planned merger with Jade Biosciences, now set for April 28, 2025, concerning a total of $69.6 million (approximately $2.40 per share) for stockholders of record by April 25, 2025.